Figure S1. Normal levels of HO-1 on monocyte-derived DCs from SLE patients.

Figure S2. Surface HO-1 expression in monocytes, lymphocytes and DCs from SLE patients.

Figure S3. Expression of MHCII and CD86 in monocytes from SLE patients.

Figure S4. Reduced HO-1 expression in monocytes and dendritic cells from RA patients.

Figure S5. HO-1 mRNA levels in Transplanted patients.

Figure S6. Altered HO-1 expression in monocytes, dendritic cells and T cells from FcγRIIb KO mice.

IMM_3598_sm_FigS1.tif218KSupporting info item
IMM_3598_sm_FigS2.tif642KSupporting info item
IMM_3598_sm_FigS3.tif953KSupporting info item
IMM_3598_sm_FigS4.tif414KSupporting info item
IMM_3598_sm_FigS5.tif218KSupporting info item
IMM_3598_sm_FigS6.tif753KSupporting info item

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.